9:10 PM | Tuesday | Oct 13, 2026
Healthcare giants UnitedHealth Group and Johnson & Johnson reported Q3 results on Tuesday, with both raising their full-year earnings outlooks but delivering contrasting reports.
Read full articleHealthcare giants UnitedHealth Group and Johnson & Johnson reported Q3 results on Tuesday, with both raising their full-year earnings outlooks but delivering contrasting reports.
Read full article
Broadcom (AVGO) CEO Hock Tan believes some AI investors don't know what products they are actually investing in, equating them to gamblers. Meanwhile, healthcare earnings gave a mixed pulse on the state of the industry even though UnitedHealth (UNH) beat.
Read full article
UnitedHealth Group Inc. (NYSE:UNH) says its Medicaid business is bottoming and expects core Medicaid margins to improving after 2026.
Read full article
UnitedHealth tops Q3 earnings estimates as lower medical costs and improved margins boost EPS 60.6%, prompting management to raise its 2026 earnings outlook.
Read full article
Revenue: $113 billion in Q3 2026.Adjusted EPS: $4.69 in Q3 2026, up from $2.92 a year ago.Consolidated Medical Care Ratio: 88.
4% in Q3 2026, compared to 89.9% l
UnitedHealth Group Incorporated (UNH) Q3 2026 Earnings Call Transcript
Read full article
UnitedHealth Group Incorporated delivered a solid Q3 with a beat and raise, driven by improved medical cost management and operating income growth. UNH's medical cost ratio declined YoY to 88.4%, reflecting strong execution and pricing discipline, though industry complexities persist. Optum's margin improvement and AI-driven efficiencies signal structural gains, but valuation concerns and external risks temper enthusiasm.
Read full article
UnitedHealth Group Inc. (NYSE:UNH) beat third-quarter estimates on Tuesday and raised its informal full-year outlook for 2026. Management also told analysts their 2027 numbers look too conservative.
Read full article
UnitedHealth Group Incorporated delivered Q3 2026 beats on both top and bottom lines, raising full-year guidance and reaffirming a fundamental turnaround under new management. UNH's margin profile is improving, with MCR and OCR both better than expected, driven by shedding unprofitable businesses and focusing on efficiency and technology investment. Shareholder returns remain robust, combining a forward dividend yield of 2.48% and significant buybacks for a total yield near 5%, supported by strong cash generation.
Read full article
UnitedHealth (UNH) shares initially rallied after posting an earnings beat on the top and bottom line, with guidance also coming in above Wall Street estimates. The stock reversed within the first hour of the trading day.
Read full article
UnitedHealth Group NYSE: UNH reported third-quarter 2026 revenue of $113 billion and adjusted earnings per share of $4.69, compared with $2.92 a year earlier, as the healthcare company cited improving execution across UnitedHealthcare and Optum.
Read full article
Although the revenue and EPS for UnitedHealth (UNH) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read full article
UnitedHealth Group Inc (NYSE:UNH, XETRA:UNH), the US healthcare group, raised its 2026 earnings outlook after third-quarter operating earnings increased 52% to $6.6 billion, supported by lower medical costs and improved operational performance. The company now expects adjusted earnings of at least $20.50 a share for 2026, up from $18.15 in 2025, following results that exceeded the previous year's performance.
UnitedHealth Group shares are on the rise after a better-than-expected earnings report.
Read full article
UnitedHealth Group (NYSE:UNH | UNH Price Prediction) shares are up 4% to $395.19 after the health insurer topped Q3 2026 profit estimates and raised its full-year outlook.
Read full article
UnitedHealth Group Incorporated delivered a strong Q3 double beat, with EPS 13% above consensus and clear margin improvement. UNH's turnaround strategy—shedding unprofitable patient groups and focusing on cost control—drove net margin expansion from 2.1% to 3.6%. Management raised 2026 EPS guidance to at least $20.
50, reflecting confidence in ongoing profitability improvements.
Big bank earnings are in focus as third-quarter earnings season kicks off, but several other major names are reporting results as well.
Read full article
Stocks are moving in opposite directions this morning, with Dow futures surging over 350 points
Read full article
UnitedHealth Group (UNH) came out with quarterly earnings of $4.69 per share, beating the Zacks Consensus Estimate of $4.12 per share. This compares to earnings of $2.92 per share a year ago.
NorthCrest Asset Manangement LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE: UNH) by 41.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 24,897 shares of the healthcare conglomerate's stock after acquiring an additional 7,273 shares
Read full article
Shares of UnitedHealth Group Incorporated (NYSE:UNH) rose sharply in pre-market trading after the company posted upbeat third-quarter results.
Read full article
AI stocks drop as investors lock in some profit ahead of earnings season while UnitedHealth rallies following strong third-quarter earnings.
Read full article
The health-insurance giant said its medical-cost ratio was 88.4% in the third quarter of this year as the company tries to rein in spending on medical care.
Read full article
UnitedHealth Group reported third-quarter net income of $4.11 billion, or $4.56 a share. That compared with net income of $2.35 billion, or $2.
59 a share, a year earlier.
UnitedHealth Group (NYSE: UNH) today reported third quarter 2026 results and raised guidance for full year 2026.This press release features multimedia. View the
Read full article
UnitedHealth Group posted third-quarter earnings that blew past estimates and raised its full-year profit outlook. The nation's largest private insurer continues to manage high medical costs and is seeing investments in value-based care and artificial intelligence take hold, CFO Wayne DeVeydt said in an interview.
Read full article
Spending on medical costs—a pain point for large insurers in recent years—continued to show signs of improvement.
Read full article
--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) today reported third quarter 2026 results and raised guidance for full year 2026. “Our third quarter results reflect the discipline and execution our teams are bringing to every part of our business, as we continue evolving UnitedHealth Group to deliver a simpler, more supportive experience for patients and the clinicians who care for them,” said Stephen Hemsley, chief executive officer of UnitedHealth Group. The company now expects full year 20.
Read full article
UnitedHealth Group Incorporated delivered a solid Q3 with a beat and raise, driven by improved medical cost management and operating income growth. UNH's medical cost ratio declined YoY to 88.4%, reflecting strong execution and pricing discipline, though industry complexities persist. Optum's margin improvement and AI-driven efficiencies signal structural gains, but valuation concerns and external risks temper enthusiasm.
Read full articleUnitedHealth Group Inc. (NYSE:UNH) beat third-quarter estimates on Tuesday and raised its informal full-year outlook for 2026. Management also told analysts their 2027 numbers look too conservative.
Read full article
UnitedHealth Group Incorporated delivered Q3 2026 beats on both top and bottom lines, raising full-year guidance and reaffirming a fundamental turnaround under new management. UNH's margin profile is improving, with MCR and OCR both better than expected, driven by shedding unprofitable businesses and focusing on efficiency and technology investment. Shareholder returns remain robust, combining a forward dividend yield of 2.48% and significant buybacks for a total yield near 5%, supported by strong cash generation.
Read full article
UnitedHealth (UNH) shares initially rallied after posting an earnings beat on the top and bottom line, with guidance also coming in above Wall Street estimates. The stock reversed within the first hour of the trading day.
Read full article
UnitedHealth Group NYSE: UNH reported third-quarter 2026 revenue of $113 billion and adjusted earnings per share of $4.69, compared with $2.92 a year earlier, as the healthcare company cited improving execution across UnitedHealthcare and Optum.
Read full article
Although the revenue and EPS for UnitedHealth (UNH) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read full article
UnitedHealth Group Inc (NYSE:UNH, XETRA:UNH), the US healthcare group, raised its 2026 earnings outlook after third-quarter operating earnings increased 52% to $6.6 billion, supported by lower medical costs and improved operational performance. The company now expects adjusted earnings of at least $20.50 a share for 2026, up from $18.15 in 2025, following results that exceeded the previous year's performance.
UnitedHealth Group shares are on the rise after a better-than-expected earnings report.
Read full article
UnitedHealth Group (NYSE:UNH | UNH Price Prediction) shares are up 4% to $395.19 after the health insurer topped Q3 2026 profit estimates and raised its full-year outlook.
Read full article
UnitedHealth Group Incorporated delivered a strong Q3 double beat, with EPS 13% above consensus and clear margin improvement. UNH's turnaround strategy—shedding unprofitable patient groups and focusing on cost control—drove net margin expansion from 2.1% to 3.6%. Management raised 2026 EPS guidance to at least $20.
50, reflecting confidence in ongoing profitability improvements.